Package 0024-5871-01

Brand: toujeo max

Generic: insulin glargine
NDC Package Sample

Package Facts

Identity

Package NDC 0024-5871-01
Digits Only 0024587101
Product NDC 0024-5871
Description

1 SYRINGE in 1 CARTON (0024-5871-01) / 3 mL in 1 SYRINGE

Marketing

Marketing Status
Marketed Since 2018-03-26
Brand toujeo max
Generic insulin glargine
Sample Package Yes

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "49201ad7-68f7-407c-959f-852591703f96", "openfda": {"nui": ["M0011417", "N0000175453"], "unii": ["2ZM8CX04RZ"], "rxcui": ["1604539", "1604544", "2002419", "2002420"], "spl_set_id": ["c9561d96-124d-48ca-982f-0aa1575bff36"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Sanofi-Aventis U.S. LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "1 SYRINGE in 1 CARTON (0024-5871-01)  / 3 mL in 1 SYRINGE", "package_ndc": "0024-5871-01", "marketing_start_date": "20180326"}, {"sample": false, "description": "2 SYRINGE in 1 CARTON (0024-5871-02)  / 3 mL in 1 SYRINGE (0024-5871-00)", "package_ndc": "0024-5871-02", "marketing_start_date": "20180326"}], "brand_name": "TOUJEO Max", "product_id": "0024-5871_49201ad7-68f7-407c-959f-852591703f96", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [CS]"], "product_ndc": "0024-5871", "generic_name": "insulin glargine", "labeler_name": "Sanofi-Aventis U.S. LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TOUJEO Max", "active_ingredients": [{"name": "INSULIN GLARGINE", "strength": "300 U/mL"}], "application_number": "BLA206538", "marketing_category": "BLA", "marketing_start_date": "20150215", "listing_expiration_date": "20261231"}